Fiscal Period | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
Total Operating Expense | 6,821.65 | 5,750.87 | 5,070.56 | 4,769.93 |
Other Net | 67.26 | -21.27 | -14.68 | -15.92 |
Diluted Weighted Average Shares | 18.70 | 18.91 | 18.91 | 18.91 |
Depreciation/ Amortization | 384.13 | 312.41 | 260.12 | 244.86 |
Operating Income | 1,074.35 | 907.39 | 915.25 | 1,085.46 |
Net Income | 681.33 | 498.18 | 532.02 | 662.20 |
Income Availableto Com Excl Extra Ord | 681.33 | 498.18 | 532.02 | 662.20 |
Other Operating Expenses Total | 1,834.25 | 919.76 | 829.78 | 785.84 |
Net Income Before Taxes | 971.35 | 727.23 | 747.21 | 972.55 |
Minority Interest | -26.14 | -29.39 | -29.83 | -40.36 |
Net Income After Taxes | 707.47 | 527.58 | 561.85 | 702.56 |
Income Availableto Com Incl Extra Ord | 681.33 | 498.18 | 532.02 | 662.20 |
Costof Revenue Total | 3,146.60 | 2,595.46 | 2,369.11 | 2,330.43 |
Gross Profit | 4,749.39 | 4,062.79 | 3,616.70 | 3,524.95 |
Interest Inc( Exp) Net- Non- Op Total | -170.26 | -166.08 | -153.03 | -96.58 |
Unusual Expense( Income) | 10.38 | 9.93 | 6.15 | - |
Diluted Net Income | 681.33 | 498.18 | 532.02 | 662.20 |
DPS- Common Stock Primary Issue | 3.00 | - | - | - |
Provisionfor Income Taxes | 263.88 | 199.65 | 185.37 | 269.99 |
period Type | - | - | - | - |
Net Income Before Extra Items | 681.33 | 498.18 | 532.02 | 662.20 |
Total Revenue | 7,896.00 | 6,658.25 | 5,985.81 | 5,855.39 |
period Length | 12.00 | 12.00 | 12.00 | 12.00 |
Revenue | 7,896.00 | 6,658.25 | 5,985.81 | 5,855.39 |
Selling/ General/ Admin Expenses Total | 1,446.29 | 1,913.31 | 1,605.41 | 1,408.80 |
Diluted Normalized EPS | 36.83 | 26.45 | 28.39 | 35.03 |
Diluted EPS Excluding Extra Ord Items | 36.43 | 26.35 | 28.13 | 35.02 |
Gain( Loss)on Saleof Assets | - | 7.19 | -0.33 | -0.41 |
Emcure Pharmaceuticals Dividend Emcure Pharmaceuticals Bonus Emcure Pharmaceuticals News Emcure Pharmaceuticals AGM Emcure Pharmaceuticals Rights Emcure Pharmaceuticals Splits Emcure Pharmaceuticals Board Meetings Emcure Pharmaceuticals Key Metrics Emcure Pharmaceuticals Shareholdings Emcure Pharmaceuticals Balance Sheet Emcure Pharmaceuticals Cashflow Emcure Pharmaceuticals Q1 Results Emcure Pharmaceuticals Q2 Results Emcure Pharmaceuticals Q3 Results Emcure Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks